skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. Using their extensive experience, supported by data from Datamonitor Healthcare, Biomedtracker, and Pharmapremia, the analysts will examine:

  • The projected impacts of important near-term regulatory milestones
  • Upcoming critical reimbursement decisions and their effects
  • Recently-released trial data and its impact on Likelihood of Phase/PDUFA review success, overall Likelihood of Approval, and sales potential of key therapies

Download Webinar Slides

 

おすすめのニュース&レポート

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Scrip: 世界の医療用医薬品&製薬産業に関するニ...

    39th Annual J.P. Morgan Healthcare Conference 2021

    Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

  • ターゲット市場の実像をつかむ

    Pharma Must Not Let Its COVID-19 Halo Slip

    By Daniel Chancellor

    Biopharma’s accomplishments in tackling the global COVID-19 pandemic, unlike advances within oncology such as cell therapies and checkpoint inhibitors, or functional cures for HIV and hepatitis C, have captured the public’s imagination.

    Topics Coronavirus $name BioPharmaceutical

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    2021 Clinical Development Success Rates

    This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

    Topics Clinical Trials Drug Development Landscape Drug Pricing

;

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com

*Omdia(ICT産業の情報)に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。